55/100BPROLOGIS stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for PROLOGIS is 154.21, 19.7% above the current price of 128.83. Their targets range from 136.00 to 170.00.
Of the 17 firms that rated PROLOGIS in the past 12 months, 12 rate it buy or strong buy, 5 hold and 0 sell or strong sell (each firm at its latest rating): a Buy consensus.
Analysts' 1-year price targets range from 136.00 to 170.00, with an average of 154.21.
| Buy | 12 | |
| Hold | 5 | |
| Sell | 0 |
12-month price target
| Highest target | 170.00 |
| Average target | 154.21 |
| Lowest target | 136.00 |
| Current price | 128.83 |
PROLOGIS price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their PROLOGIS price target and rating?
How analysts rate PROLOGIS, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
12 of 17 firms rate it buy now, against 9 of 16 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
PROLOGIS analyst upgrades, downgrades and price targets
The latest rating change came on 21 October 2026, when Raymond James upgraded PROLOGIS from Market Perform to Outperform. Its price target is 163.00. The most recent new target came from Jefferies on 2 November 2026: 149.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 2 Nov 2026 | Jefferies Jonathan Petersen | — | 149.00 | — | 128.06 |
| 23 Oct 2026 | Truist Financial | — | 154.00 → 141.00 | -8.4% | 126.44 |
| 21 Oct 2026 | Raymond James David Rodgers | Upgraded · Market Perform → Outperform | 163.00 | — | 127.47 |
| 20 Oct 2026 | Robert W. Baird Nicholas Thillman | — | 140.00 → 136.00 | -2.9% | 124.09 |
| 16 Oct 2026 | UBS | — | 161.00 → 150.00 | -6.8% | 127.43 |
| 16 Oct 2026 | Williams Trading | — | 150.00 | — | 127.43 |
| 13 Oct 2026 | Scotiabank | Upgraded · Sector Perform → Sector Outperform | — | — | — |
| 1 Sept 2026 | Wells Fargo | Reiterated · Overweight | 166.00 | — | 139.94 |
| 5 Aug 2026 | RBC Capital | Upgraded · Sector Perform → Outperform | — | — | — |
| 4 Aug 2026 | RBC Capital | — | 148.00 → 160.00 | +8.1% | 139.05 |
| 31 Jul 2026 | Robert W. Baird Nicholas Thillman | — | 130.00 → 140.00 | +7.7% | 146.19 |
| 23 Jul 2026 | Scotiabank | Reiterated · Sector Perform | 154.00 → 150.00 | -2.6% | 143.44 |
| 17 Jul 2026 | Mizuho Securities | Reiterated · Outperform | 143.00 → 159.00 | +11.2% | 149.96 |
| 16 Jul 2026 | Barclays | Reiterated · Overweight | 139.00 → 156.00 | +12.2% | 143.42 |
| 1 Jul 2026 | BTIG | Reiterated · Buy | 155.00 → 170.00 | +9.7% | 135.47 |
| 29 Jun 2026 | BMO Capital John Kim | Reiterated · Outperform | 123.00 → 158.00 | +28.5% | 139.97 |
| 18 Jun 2026 | Scotiabank | Downgraded · Sector Outperform → Sector Perform | — | — | — |
| 26 May 2026 | Morgan Stanley Ronald Kamdem | — | 135.00 → 151.00 | +11.9% | 147.39 |
| 7 May 2026 | BMO Capital | Upgraded · Market Perform → Outperform | — | — | — |
| 28 Apr 2026 | RBC Capital | Reiterated · Sector Perform | 135.00 → 148.00 | +9.6% | 140.02 |
| 27 Apr 2026 | Truist Financial | Reiterated · Buy | 139.00 → 154.00 | +10.8% | 141.34 |
| 21 Apr 2026 | Scotiabank Nicholas Yulico | Reiterated · Sector Outperform | 146.00 → 154.00 | +5.5% | 142.43 |
| 17 Apr 2026 | Goldman Sachs | — | 157.00 | — | 145.10 |
| 17 Apr 2026 | Evercore ISI Steve Sakwa | Reiterated · In Line | 121.00 → 135.00 | +11.6% | 144.46 |
| 17 Apr 2026 | UBS | Reiterated · Buy | 148.00 → 161.00 | +8.8% | 144.72 |
| 9 Mar 2026 | Industrial Alliance Securities | — | 119.00 → 153.00 | +28.6% | 135.15 |
| 2 Feb 2026 | RBC Capital Michael Carroll | Reiterated · Sector Perform | 135.00 | — | 130.35 |
| 26 Jan 2026 | Truist Financial Michael Lewis | Reiterated · Buy | 131.00 → 139.00 | +6.1% | 127.55 |
| 26 Jan 2026 | Mizuho Securities | Reiterated · Outperform | 118.00 → 143.00 | +21.2% | 127.15 |
| 23 Jan 2026 | Freedom Capital Markets | Downgraded · Buy → Hold | — | — | — |
| 23 Jan 2026 | Freedom Broker | Downgraded · Buy → Hold | — | — | — |
| 22 Jan 2026 | BMO Capital | — | 119.00 → 123.00 | +3.4% | 128.42 |
| 22 Jan 2026 | Argus Research Marie Ferguson | Reiterated · Buy | 135.00 | — | 128.50 |
| 22 Jan 2026 | Evercore ISI | Reiterated · In Line | 121.00 | — | 128.48 |
| 22 Jan 2026 | UBS | Reiterated · Buy | 146.00 → 148.00 | +1.4% | 130.59 |
| 16 Jan 2026 | Morgan Stanley Ronald Kamdem | — | 135.00 | — | 133.19 |
| 14 Jan 2026 | UBS Nicholas Yulico | — | 144.00 → 146.00 | +1.4% | 130.22 |
| 14 Jan 2026 | Scotiabank | Upgraded · Sector Perform → Sector Outperform | 114.00 → 146.00 | +28.1% | 130.22 |
| 13 Jan 2026 | Barclays | — | 139.00 | — | 128.44 |
| 8 Jan 2026 | UBS | Reiterated · Buy | 138.00 → 144.00 | +4.3% | 126.90 |
| 8 Jan 2026 | Robert W. Baird Nicholas Thillman | — | 130.00 | — | 126.90 |
| 8 Jan 2026 | Baird | Downgraded · Outperform → Neutral | — | — | — |
| 31 Dec 2025 | BTIG | Reiterated · Buy | 155.00 | — | 129.01 |
| 4 Dec 2025 | UBS | — | 133.00 → 138.00 | +3.8% | 129.19 |
PROLOGIS EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect PROLOGIS's EPS to grow 1.0% a year until 2028. Over the last 5 years it grew 12.8% a year, and over the last 3 years it fell 5.7%.
Analysts expect PROLOGIS's revenue to grow 5.8% a year until 2028, slower than over the last 5 years (14.6% a year) and the last 3 years (13.7%).
Revenue
EPS
Does PROLOGIS beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 49.0% off the result, either way, and their revenue estimate 1.5%, over the last 12 quarters.
- EPS beats
- 78 / 100
- Revenue beats
- 77 / 100
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +47.0%
- Since
- January 2001
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 15 Oct 2026 | 0.78 | 1.60 | +105.9% | 2.18B | 2.39B | +9.7% |
| Q2 FY2026 | 16 Jul 2026 | 0.75 | 1.13 | +51.3% | 2.16B | 2.18B | +0.7% |
| Q1 FY2026 | 16 Apr 2026 | 0.81 | 1.05 | +30.3% | 2.12B | 2.13B | +0.2% |
| Q4 FY2025 | 21 Jan 2026 | 0.74 | 1.49 | +102.2% | 2.09B | 2.09B | +0.1% |
| Q3 FY2025 | 15 Oct 2025 | 0.67 | 0.82 | +22.8% | 2.03B | 2.05B | +1.2% |
| Q2 FY2025 | 16 Jul 2025 | 0.69 | 0.61 | -11.7% | 2.01B | 2.03B | +0.9% |
| Q1 FY2025 | 16 Apr 2025 | 0.63 | 0.65 | +2.8% | 1.96B | 1.99B | +1.2% |
| Q4 FY2024 | 21 Jan 2025 | 0.64 | 1.38 | +115.6% | 1.94B | 1.94B | -0.3% |
| Q3 FY2024 | 16 Oct 2024 | 0.63 | 1.08 | +71.4% | 1.91B | 1.90B | -0.5% |
| Q2 FY2024 | 17 Jul 2024 | 0.62 | 0.92 | +49.4% | 1.86B | 1.85B | -0.4% |
| Q1 FY2024 | 17 Apr 2024 | 0.58 | 0.63 | +8.6% | 1.82B | 1.83B | +0.3% |
| Q4 FY2023 | 17 Jan 2024 | 0.59 | 0.68 | +15.6% | 1.81B | 1.76B | -2.8% |
PROLOGIS stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If PROLOGIS's earnings keep growing at the 0.9% a year analysts expect to FY2028, it would earn about 3.73 a share in FY2030. At the P/E it has traded at over the last five years (26.2 to 43.6) that is 97.90 to 162.80 a share, or 125.38 at its average P/E of 33.6. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 3.76 | 98.53 | 126.19 | 163.85 |
| FY2027 | 3.34 | 87.52 | 112.08 | 145.53 |
| FY2028 | 3.67 | 96.17 | 123.16 | 159.93 |
| FY2029 (extrapolated) | 3.70 | 97.03 | 124.26 | 161.36 |
| FY2030 (extrapolated) | 3.73 | 97.90 | 125.38 | 162.80 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 0.9% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (26.2, 33.6, 43.6).
Is PROLOGIS stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
PROLOGIS's P/E of 28.4 is near the bottom of its 5-year range (20.5 to 43.7, median 34.3). Analysts expect slower growth than in recent years, so the low P/E may be deserved. Buyers pay more for each point of growth than usual: a PEG of 28.7 on expected growth against 2.7 on its median P/E and past five years' growth. At its usual P/E (34.3 × EPS of 4.54), PROLOGIS's fair value is 155.79; the price, 128.83, is 17.3% below it. Its forward P/E, on the consensus for FY2026, is 34.3.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (20.5 and 43.7). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 28.38
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 34.32
- Five-year P/E range
- 20.5 – 43.7
- Forward P/E (FY2026)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 34.29
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 31.72
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +19.7%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 35.850 | 71.4258Price 35.85193 | +99.2% | |
| 29.050 | 56.2634Price 29.0596 | +93.7% | |
| 241.000 | 464.49205Price 241.00627 | +92.7% | |
| 123.590 | 237.24178Price 123.59297 | +92.0% | |
| 161.400 | 305.52159Price 161.40396 | +89.3% | |
| 157.460 | 297.58169Price 157.46471 | +89.0% | |
| 217.560 | 405.38304Price 217.56507 | +86.3% |
Furthest below the fair value on each stock's page, updated every day.